Tag Archives: Medicaid

Pharma Pricing Top Target for Medicare Cutbacks

In the dog-eat-dog world of federal deficit reduction, there seems to be one health-related spending cut with broad bi-partisan support:  require drug companies to give the federal government “a better deal on medications for low-income people on Medicare.” Nearly 70% of respondents back this strategy, according to a survey sponsored by the Kaiser Family Foundation […]
Posted in healthcare, pricing | Also tagged , , , , , , | 2 Comments

Sequestration: What Does it Mean for Pharma?

You may have read horror stories about the looming Sequestration Act, but what exactly is it? And what does it mean for US pharma? Tom Norton reports. Lurking in the shadows of the US General Elections is something called The Sequestration Transparency Act of 2011. Of late, you may have read the occasional article that […]
Posted in Guest Blog, Regulatory | Also tagged , , , , , | 2 Comments

Affordable Care Act: Where's the Sunshine?

Where’s the Sunshine? The Senate Special Committee on Aging is holding a Roundtable discussion on Wed. Sept. 12, 2012 in hopes of spurring action to implement the “Sunshine” provisions of the Affordable Care Act (ACA). Policies for collecting and submitting information on pharma payments to doctors were supposed to be issued by last September (2011), […]
Posted in Guest Blog, healthcare, Op-Ed, Regulatory | Also tagged , , , | Leave a comment

Paul Ryan and Pharma: The Inside Story

by Tom Norton Well, we certainly have a presidential campaign now, don’t we? Good grief. Since Rep. Paul Ryan was named the Republican VP candidate last week, all hell has broken loose!  Given the intensity of the last few days, you’d think the election was tomorrow… And at some point, you do have to ask […]
Posted in FDA, Guest Blog, healthcare, Op-Ed | Also tagged , , , , | 3 Comments

Drug Reimbursement and the "New Medicaid"

by Tom Norton A lot has been written about the “state option” created by the Supreme Court ruling on HCR, and what it means to American medicine. Sorting out an opinion will, to a degree, depend on whom you read and what you believe. But regardless of where you come out on this issue, there […]
Posted in Guest Blog, healthcare, Legal, Market Access, R&D, Regulatory | Also tagged , , , , , , , | 1 Comment
  • Categories

  • Meta